Apparent insensitivity of the hotplate latency test for detection of antinociception following Intraperitoneal, Intravenous or Intracerebroventricular M6G Administration to Rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1326-1332

  South, Samantha M ^a   Smith, Maree T ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; MORPHINE 6 GLUCURONIDE; MORPHINE DERIVATIVE; MORPHINE-6-GLUCURONIDE; NARCOTIC ANALGESIC AGENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CONTROLLED STUDY; HOT PLATE TEST; INTERMETHOD COMPARISON; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; ANIMAL; DOSE RESPONSE; DRUG EFFECT; REFLEX; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; BLOOD-BRAIN BARRIER; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; MORPHINE DERIVATIVES; RATS; RATS, SPRAGUE-DAWLEY; REFLEX;

EID: 0032161859     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aasmundstad TA, Morland J and Paulsen RE (1995) Distribution of morphine-6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 275: 435-441.
2. Abbott FV and Palmour RM (1988) Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sei 43:1685-1695.
3. Avdeef A, Barrett-DA, Shaw PN, Knaggs RD and Davis SS (1996) pH metric logP octanol, chloroform, and propylene glycol dipelargonat water partitioning of morphine-6-glucuronide and other related opiates. J Med Chem 39:4377-4381.
4. Azzi G, Bernaudin JF, Bouchaud C, Bellon B and Fleury-Feith J ( 1990) Permeability of the normal rat brain, spinal cord and dorsal root ganglia microcirculations to immunoglobulins G. Cell 68:31-36.
5. Brady LS and Holtzman SG (1982) Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats. J Pharmacol Exp Ther 222:190-197.
6. Carrupt P, Testa B, Bechalany A, Tayar NE, Descas P, Perrissoud D (1991) Morphine-6-glucuronide and morphine-3-glucuronide as molecular chameleons with unexpected lipophilicity. J Med Chem 34:1272-1275.
7. D'Amour FE and Smith DL ( 1941 ) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
8. Eddy NB and Leimbach D (1953) Synthetic Analgesics. II. Dithienylbutenyl and Dithienylbutylamines. J Pharmacol Exp Ther 107:385-393.
9. Frances B, Gout R, Monsarrat B, Cros J and Zajac J (1992) Further evidence that morphine-6-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ther 262:25-31.
10. Gong Q, Hedner T, Hedner J, Bjorkman R and Nordberg G (1991) Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 193:47-56.
11. Gong Q, Hedner J, Bjorkman R and Hedner T (1992) Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 48:249-255.
12. Grossman ML, Basbaum AI and Fields HL U982) Afferent and Efferent Connections of the Rat Tail Flick Reflex: A model used to analyse pain control mechanisms. J Comp Neural 206:9-16.
13. Hand C, Blunnie WP, Claffey LP, McShane AJ, McQuay HJ and Moore RA (1987) Potential analgesic contribution from morphine-6-glucuronide in CSF. The Lancet ii.:1207-1208.
14. Heyman JS, Williams CL, Burks TF, Mosberg HI and Porreca F (1988) Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J Pharmacol Exp Ther 245:238-243.
15. Hug CJr (1967) Transport of narcotic analgesics by choroid plexus and kidney tissue in vitro. Biochem Pharmacol 16:345-359.
16. Irwin S, Houde RW, Bennet DR, Hendershot LC and Seevers MH (1951) The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J Pharmacol Exp Ther 101:132-143.
17. Langerman L, Zabowski MI, Piskoun B and Grant GJ (1995) Hot Plate us. Tail Flick: Evaluation of acute tolerance to continuous morphine infusion in the rat model. J Pharmacol Toxicol Meth 34:23-27.
18. Ling GSF and Pasternak GW (1983) Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites. Brain Res 271:152-156.
19. Lukas G, Brindle SD and Greencard P (1971) The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther 178:562-566.
20. Miaskowski C, Taiwo YO and Levine JD (1993) Antinociception produced by receptor selective opioids. Modulation of supraspinal antinociceptive effects by spinal opioids. Brain Res 608:87-94.
21. Morgan MM, Sohn JH and Liebeskind JC (1989) Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level. Brain Res 502:61-66.
22. Pasternak GW, Bodnar RJ: Clark JA and Inturrisi CE (1987) Morphine-6glucuronide, a potent mu agonist. Life Sei 41:2845-2849.
23. Pastoriza LN, Morrow TJ and Casey KL (1996) Medial frontal cortex lesions selectively attenuate the Hot Plate response-possible nocifensive apraxia in the rat. Pain 64:11-17.
24. Paul D, Standifer KM: Inturrisi CE and Pasternak GW (1989) Pharmacological characterisation of morphine-6-glucuronide: a very potent morphine metabolite. J Pharmacol Exp Ther 251:477-483.
25. nd Ed. Academic Press, Inc., San Diego.
26. 2-opioid receptors mediate spinal/supraspinal morphine synergy. Eur J Pharmacol 220:275277.
27. Pick CG, Nejat RJ arid Pasternak GW (1993) Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J Pharmacol Exp Ther 265:166-171.
28. 5] enkephalin in the mouse. J Pharmacol Exp Ther 241:393-400.
29. Prankerd RJ (1993) A molecular modelling study of the zwitterionic forms of the major morphine metabolites, morphine-3-glucuronide and morphine-6-glucuronide. Abstract, Aust J Hasp Pharm 24:210.
30. Ramabadran K and Bansinath M (1986) A critical analysis of the experimental evaluation of nociceptive reactions in animals. Pharmaceut Res 3:263-270.
31. Smith GM and Shine HD (1992) Immunofluorescent labeling of tight junctions in the rat brain and spinal cord. Int J Dev Neurosci 10:387-392.
32. Sullivan AF, McQuay HJ, Bailey D and Dickenson AH (1989) The spinal antinociceptive actions of morphine metabolites, morphine-6-glucuronide and normorphine in the rat. Brain Res 482:219-224.
33. Wright AWE, Watt JA, Kennedy M, Cramond T and Smith MT (1994) Quantitäten of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. Ther Drug Monit 16:200-208.
34. Wu DF, Rang YS, Bickel U and Pardridge WM (1997) Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos 25:768-771.
35. Yeh SY, Gorodetzky CW and Krebs HA (1977) Isolation and identification of morphine 3- and 6- glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans. J Pharm Sei 66:1288-1293.
36. Yoshimura H, Ida S, Oguri K and Tsukamoto H (1973) Biochemical basis for analgesic activity of morphine-6-glucuronide: penetration of morphine-6-glucuronide in the brain of rats. Biochem Pharmacol 22:1423-1430.
37. Send reprint requests to: Dr. Maree T. Smith, School of Pharmacy, Steele Building, The University of Queensland, Brisbane, QLD 4072 AustraLa. E-mail: maree.smith@pharmacy.uq.edu.au